Market capitalization | €56.60b |
Enterprise Value | €70.20b |
P/E (TTM) P/E ratio | 29.14 |
EV/FCF (TTM) EV/FCF | 39.59 |
EV/Sales (TTM) EV/Sales | 3.14 |
P/S ratio (TTM) P/S ratio | 2.53 |
P/B ratio (TTM) P/B ratio | 3.10 |
Dividend yield | 1.88% |
Last dividend (FY23) | €0.95 |
Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.
20 Analysts have issued a Siemens Healthineers forecast:
20 Analysts have issued a Siemens Healthineers forecast:
Sep '24 |
+/-
%
|
||
Revenue | 22,363 22,363 |
3%
3%
|
|
Gross Profit | 8,469 8,469 |
10%
10%
|
|
EBITDA | 4,284 4,284 |
7%
7%
|
EBIT (Operating Income) EBIT | 3,061 3,061 |
24%
24%
|
Net Profit | 1,942 1,942 |
29%
29%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
Head office | Germany |
CEO | Bernhard Montag |
Employees | 72,300 |
Founded | 2017 |
Website | www.siemens-healthineers.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.